Postoperative surveillance of thyroid carcinoma

Oral Oncology

Volumn 49, Issue 7, 2013, Pages 684-688

  McIver, Bryan ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; FETAL ANTIGEN; IODINE 123; IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROTROPIN; THYROXINE; TUMOR MARKER;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER SCINTISCANNING; CANCER SURGERY; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DRUG COST; DRUG HALF LIFE; DRUG MEGADOSE; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; HUMAN; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROID SCINTISCANNING; THYROID SURGERY; TUMOR BIOPSY; WHOLE BODY SCINTISCANNING;

HUMANS; POSTOPERATIVE PERIOD; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84879124696     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.03.436     Document Type: Article

References (37)

1. E.L. Mazzaferri Papillary and follicular thyroid cancer: a selective approach to diagnosis and treatment Annu Rev Med 32 1981 73 91
2. D. Zimmerman, I.D. Hay, and I.R. Gough Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades Surgery 104 1988 1157 1166
3. K. Viswanathan, T.C. Gierlowski, and A.B. Schneider Childhood thyroid cancer. Characteristics and long-term outcome in children irradiated for benign conditions of the head and neck Arch Pediatr Adolesc Med 148 1994 260 265
4. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, and S.J. Mandel American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid. 19 2009 1167 1214
5. S.K. Grebe, and I.D. Hay Thyroid cancer nodal metastases: biologic significance and therapeutic considerations Surg Oncol Clin N Am 5 1996 43 63
6. R.M. Tuttle, G. Rondeau, and N.Y. Lee A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer Cancer Control 18 2011 89 95
7. A.T. Ahuja, L. Chow, W. Chick, W. King, and C. Metreweli Metastatic cervical nodes in papillary carcinoma of the thyroid: ultrasound and histological correlation Clin Radiol 50 1995 229 231
8. C.R. Hopkins, and C.C. Reading Thyroid and parathyroid imaging Semin Ultrasound CT MR 16 1995 279 295
9. Moon JH, Kim YI, Lim JA, Choi HS, Cho SW, Kim KW, et al. Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results. J Clin Endocrinol Metab; 2013 February 7. [Epub ahead of print].
10. F. Grunwald, C. Menzel, and H. Bender Redifferentiation therapy-induced radioiodine uptake in thyroid cancer J Nucl Med 39 1998 1903 1906
11. H.M. Park, Y.H. Park, and X.H. Zhou Detection of thyroid remnant/metastasis without stunning: an ongoing dilemma Thyroid 7 1997 277 280
12. W. Yaakob, L. Gordon, K.M. Spicer, and S.J. Nitke The usefulness of iodine-123 whole-body scans in evaluating thyroid carcinoma and metastases J Nucl Med Technol 27 1999 279 281
13. K.D. Denicoff, R.T. Joffe, M.C. Lakshmanan, J. Robbins, and D.R. Rubinow Neuropsychiatric manifestations of altered thyroid state Am J Psychiatry 147 1990 94 99
14. M.D. Ringel, and P.W. Ladenson Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism J Clin Endocrinol Metab 81 1996 1724 1725
15. J. Robbins Pharmacology of bovine and human thyrotropin: an historical perspective Thyroid 9 1999 451 453
16. J. Lee, M.J. Yun, K.H. Nam, W.Y. Chung, E.Y. Soh, and C.S. Park Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma Thyroid. 20 2010 173 179
17. C.A. Meier, L.E. Braverman, and S.A. Ebner Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study) J Clin Endocrinol Metab 78 1994 188 196
18. P.W. Ladenson, L.E. Braverman, and E. Mazzaferri Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma N Engl J Med 337 1997 888 896
19. B.R. Haugen, F. Pacini, and C. Reiners A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer J Clin Endocrinol Metab 84 1999 3877 3885
20. U. Mallick, C. Harmer, B. Yap, J. Wadsley, S. Clarke, and L. Moss Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer N Engl J Med 366 2012 1674 1685
21. W. Wang, H. Macapinlac, and S.M. Larson [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels J Clin Endocrinol Metabol 84 1999 2291 2302
22. W. Wang, S.M. Larson, and M. Fazzari Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer [In Process Citation] J Clin Endocrinol Metab 85 2000 1107 1113
23. Y. Krausz, A. Rosler, and H. Guttmann Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid Clin Nucl Med 24 1999 256 260
24. C.J. Wilson, J.M. Woodroof, and D.A. Girod First report of Hurthle cell carcinoma revealed by octreotide scanning Ann Otol Rhinol Laryngol 107 1998 847 850
25. C.A. Spencer, J.S. LoPresti, S. Fatemi, and J.T. Nicoloff Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement Thyroid 9 1999 435 441
26. S.K.G. Grebe, and I.D. Hay Management of differentiated thyroid cancer Curr Opin Endocrinol Diabetes 2 1995 449 454
27. C. Westbury, L. Vini, C. Fisher, and C. Harmer Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin Thyroid 10 2000 171 176
28. J.C. Sisson, N.W. Thompson, T.J. Giordano, B.G. England, and D.P. Normolle Serum thyroglobulin levels after thyroxine withdrawal in patients with low-risk papillary thyroid carcinoma Thyroid 10 2000 165 169
29. R.P. Padovani, E. Robenshtok, M. Brokhin, and R.M. Tuttle The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland Thyroid 22 2012 884 889
30. C. Rubino, F. de Vathaire, M.E. Dottorini, P. Hall, C. Schvartz, and J.E. Couette Second primary malignancies in thyroid cancer patients Br J Cancer 89 9 2003 Nov 3 1638 1644
31. C.A. Spencer Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC) J Clin Endocrinol Metab 96 2011 3615 3627
32. G. Tallini, R.A. Ghossein, and J. Emanuel Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease J Clin Oncol 16 1998 1158 1166
33. M.D. Ringel, P.W. Ladenson, and M.A. Levine Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood [see comments] J Clin Endocrinol Metab 83 1998 4435 4442
34. M.D. Ringel, P.L. Balducci-Silano, and J.S. Anderson Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma J Clin Endocrinol Metab 84 1999 4037 4042
35. J.A. van Heerden, C.S. Grant, H. Gharib, I.D. Hay, and D.M. Ilstrup Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma Ann Surg 212 1990 395 400
36. G. Mendelsohn, S.A. Wells Jr., and S.B. Baylin Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease Cancer 54 1984 657 662
37. J.A. Meijer, S. le Cessie, W.B. van den Hout, J. Kievit, J.W. Schoones, and J.A. Romijn Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis Clin Endocrinol (Oxf). 72 2010 534 542